Literature DB >> 18805388

Anaemia in advanced chronic fasciolosis.

M A Valero1, N Gironès, M A García-Bodelón, M V Periago, I Chico-Calero, M Khoubbane, M Fresno, S Mas-Coma.   

Abstract

The association between fasciolosis-induced anaemia and related factors has been quantified in a rodent model. Haematological parameters were analysed in Wistar rats at 20 and 60 weeks post-infection (p.i.). Pigment stones and bile specimens were collected. Serum IgG1, IgG2a and IgE were determined in rat serum samples. Cytokine levels have been correlated with haematological parameters. The screening for gastrointestinal bleeding was carried out. Bacteriological bile cultures revealed viable bacteria in 53.8% of specimens at 60 weeks p.i. The results show that the type of anaemia in fasciolosis might be considered a biomarker of the chronicity period of the disease, changing from normocytic to macrocytic in the early chronic period (20 weeks p.i.) and to microcytic in the advanced chronic period (60 weeks p.i.). Likewise, changing from normochromic in the early chronic period to hypochromic in the advanced chronic period. Multivariate analysis suggested an association between anaemia and the following factors: fluke burden, eggs per gram of faeces, body area of parasite, presence of blood in faeces, IgG1 and eosinophil levels, and % of splenic weight. Of all variables analysed, the fluke burden is the one which presents the highest anaemia risk, even exceeding the variable presence of blood in faeces. The development of anaemia appears to be complex and may involve multiple mechanisms. However, to the mechanisms that until now explain Fascioliosis-related anaemia (compensatory increase in erythrocyte production and a continuous drain on iron stores resulting from the parasites' blood-sucking activities) the following causes ought to be added: haemolysis of red blood cells, the general effects of inflammation on erythropoiesis, concomitant parasitic and bacterial infections and pre-morbid nutritional abnormalities. Extrapolation to human fasciolosis is discussed. The results of the rodent model lead to the assumption that a high risk of anaemia in subjects with a heavy parasitic burden in human hyperendemic areas of fasciolosis is to be expected.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805388     DOI: 10.1016/j.actatropica.2008.08.007

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  18 in total

1.  Clinical, hematological, biochemical, and ultrasonographic aspects of Platynosomum sp. (Trematoda: Dicrocoeliidae) infection of captive Callithrix penicillata.

Authors:  Mariana Portugal Mattioli; Juliana dos Santos Batista; Marlon Ferrari; Giane Regina Paludo; Cecília Azevedo Dias; Estevam G L Hoppe; Gino Chaves da Rocha; Rafael Veríssimo Monteiro
Journal:  Primates       Date:  2016-02-27       Impact factor: 2.163

2.  Buffalo Infection by Fasciola gigantica Transmitted by Radix acuminata in Uttar Pradesh, India: A Molecular Tool to Improve Snail Vector Epidemiology Assessments and Control Surveillance.

Authors:  Kumari Sunita; Santiago Mas-Coma; Maria Dolores Bargues; Mohammad Aasif Khan; Maria Habib; Saad Mustafa; Syed Akhtar Husain
Journal:  Acta Parasitol       Date:  2021-05-21       Impact factor: 1.440

3.  Molecular characterisation of Galba truncatula, Lymnaea neotropica and L. schirazensis from Cajamarca, Peru and their potential role in transmission of human and animal fascioliasis.

Authors:  M Dolores Bargues; Patricio Artigas; Messaoud Khoubbane; Pedro Ortiz; Cesar Naquira; Santiago Mas-Coma
Journal:  Parasit Vectors       Date:  2012-08-15       Impact factor: 3.876

4.  Field evaluation of a coproantigen detection test for fascioliasis diagnosis and surveillance in human hyperendemic areas of Andean countries.

Authors:  María Adela Valero; María Victoria Periago; Ignacio Pérez-Crespo; René Angles; Fidel Villegas; Carlos Aguirre; Wilma Strauss; José R Espinoza; Patricia Herrera; Angelica Terashima; Hugo Tamayo; Dirk Engels; Albis Francesco Gabrielli; Santiago Mas-Coma
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13

Review 5.  Human fascioliasis in Argentina: retrospective overview, critical analysis and baseline for future research.

Authors:  Roberto Mera y Sierra; Veronica H Agramunt; Pablo Cuervo; Santiago Mas-Coma
Journal:  Parasit Vectors       Date:  2011-06-11       Impact factor: 3.876

6.  A new baseline for fascioliasis in Venezuela: lymnaeid vectors ascertained by DNA sequencing and analysis of their relationships with human and animal infection.

Authors:  M Dolores Bargues; L Carolina González; Patricio Artigas; Santiago Mas-Coma
Journal:  Parasit Vectors       Date:  2011-10-14       Impact factor: 3.876

Review 7.  Early Postnatal and Preschool-Age Infection by Fasciola spp.: Report of Five Cases from Vietnam and Worldwide Review.

Authors:  Nguyen Van De; Thanh Hoa Le; Veronica H Agramunt; Santiago Mas-Coma
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

8.  Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano.

Authors:  Fidel Villegas; René Angles; René Barrientos; Gary Barrios; María Adela Valero; Kamal Hamed; Heiner Grueninger; Steven K Ault; Antonio Montresor; Dirk Engels; Santiago Mas-Coma; Albis Francesco Gabrielli
Journal:  PLoS Negl Trop Dis       Date:  2012-08-07

9.  Sporadic incidence of Fascioliasis detected during hepatobiliary procedures: a study of 18 patients from Sulaimaniyah governorate.

Authors:  Tahir Abdullah Hussein Hawramy; Kamal Ahmed Saeed; Seerwan Hama Sharif Qaradaghy; Taha Ahmed Karboli; Beston Faiek Nore; Noora Hisham Abood Bayati
Journal:  BMC Res Notes       Date:  2012-12-21

10.  Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide.

Authors:  José Lino Zumaquero-Ríos; Jorge Sarracent-Pérez; Raúl Rojas-García; Lázara Rojas-Rivero; Yaneth Martínez-Tovilla; María Adela Valero; Santiago Mas-Coma
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.